Bildkälla: Stockfoto

Prostatype Genomics: Outlook after Q3 - Redeye

Prostatype are making good European launch progress with clinical evaluations, ongoing evaluations and a pipeline of new evaluations. This is a vital step towards repeat sales and clinical use of Prostatype. This progress is balanced by the fact that ongoing actual sales are still very modest.

Prostatype are making good European launch progress with clinical evaluations, ongoing evaluations and a pipeline of new evaluations. This is a vital step towards repeat sales and clinical use of Prostatype. This progress is balanced by the fact that ongoing actual sales are still very modest.
Börsvärldens nyhetsbrev
ANNONSER